• Recent interview on CNBC featured prominent analyst advising investors against “egregiously expensive” tech stocks
• SGTM is profitable company that transforms natural waste into organic gardening products, playground surface material
• Recent financial results include Q3 revenue of $5.9 million, 4,817% increase in gross profit during first half of 2020 when compared to all of 2019
• Clients include The Kroger Co., Circle K, 7-Eleven, Menards Inc. and Old Castle Lawn & Garden

COVID-19 has sent the global economy into a tailspin, forcing the closure of hundreds of thousands of businesses along with the loss of millions of jobs. The stock market, however, appears to have decoupled from reality as it sets record highs amid this global economic catastrophe (https://ibn.fm/JcHkb). Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, is a small but bright light among thousands of overvalued stocks, offering investors an opportunity to invest in an ethical, sustainable and profitable company. MBMG Group Managing Director Paul Gambles recently gave an interview on CNBC advising investors to avoid “scarily priced” IT and consumer discretionary stocks, claiming that such investments were “egregiously expensive” (https://ibn.fm/t7WmY). Citing recent statistics from the MSCI World Consumer Discretionary Price Index and the MS World Information Technology Price Index – both of which have shot up by 85% and 75% respectively since last March – Gambles suggested that these types of stocks had benefited from shifts into digital and e-commerce amid COVID-19, but noted that the trend would not last much longer. While momentum stocks in the S&P 500 have risen 28% so far this year, high-quality investments in discretionary stocks characterized by high dividends and low volatility have actually fallen. Adding to the confusion is the fact that most well-known tech “giants” such as Uber, Spotify and Airbnb have never actually turned a profit (https://ibn.fm/zrIAs). The resulting situation is creating confusion among investors and analysts struggling to make sense of a market that appears to be largely driven by investor speculation. While SGTM does not have a digital platform, app, or plans to launch satellites into space, it does offer an opportunity to invest in a profitable company that takes sustainability seriously. Through its subsidiaries and partners, SGTM collects tree debris caused by storms and hurricanes and transforms it into environmentally friendly gardening mulch products and certified organic playground surfacing material. Mulch is a multi-million dollar business that provides benefits to the earth, including natural weed control, temperature regulation, moisture retention and soil erosion prevention. Rather than allow tree debris to burden landfills, SGTM transforms it into a valuable product that is sold nationwide through contracts with corporate giants like The Kroger Co., Circle K, 7-Eleven, Menards Inc. and Old Castle Lawn & Garden. Unlike many tech stocks making headlines in the financial markets, SGTM actually turns a profit. Besides growing significantly in 2020, the company recently reported $5.9 million in Q3 revenue (https://ibn.fm/BtP1e) along with an impressive 4,817% increase in gross profit during the first half of 2020 when compared to all of 2019 (https://ibn.fm/UVcIF). With plans to uplist to NASDAQ in the near future, the company has completed a 2-year audit and commenced its FORM-10 process to become fully reporting. In an investment environment rife with volatility and speculation, SGTM offers synergistic solutions that benefit the environment while offering investors an excellent opportunity to purchase shares in a sustainable business. The company is committed to continue driving forward its mission while meeting the increasing demand for sustainable solutions to serious environmental issues. To learn more about Sustainable Green Team Ltd., view the investor presentation at https://ibn.fm/EBY3V. NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

• Pure Extracts Technologies revealed it had recently retained global consultancy to advise on application for Dealer’s License under Health Canada
• If granted, license would allow Company to cultivate, conduct research into, commercialize controlled substances
• Pure Extracts also announced it recently signed LOI to further cooperation with PURICA(TM)⁽ in field of full-spectrum mushroom-derived wellness products and co-develop CBD, mushroom product combinations
• Partnership would ideally situate Company to benefit from growing consumer interest within functional mushroom – CBD oil wellness product segments

Pure Extracts Technologies (CSE: PULL) (XFRA: A2QJAJ), a plant-based extraction company, recently revealed that it had begun the process towards applying to Health Canada for a Dealers License under the Controlled Drugs and Substances Act (“CDSA”). The CDSA, which oversees the legal access to controlled substances and regulates the production, distribution and sale of these substances in Canada, requires companies to obtain regulatory approval from Health Canada prior to carrying out activities within the sector (https://ibn.fm/A1Vpy). Pure Extracts also announced that it had retained a globally recognized operations, compliance, and regulatory firm to advise on its application so as to ensure the Company’s adherence to the criteria put forth by the regulatory body. If obtained, the Dealers License would enable Pure Extracts to procure, cultivate and harvest-controlled substances – including the likes of psychedelic mushrooms for the purpose of psilocybin extraction, conduct research into controlled substances and ultimately engage in the sale of these substances through a variety of different channels. “Having the support of one of Canada’s premiere consulting companies with subject matter proficiency in cannabis, controlled substances and other regulated consumer product industries assures that we will submit a fully-compliant Dealers License application to Health Canada in the shortest time possible,” said Pure Extracts’ CEO Ben Nikolaevsky in regard to the Company’s application. “As a plant-based extractor bringing functional mushroom products to market in Q1 2021, we are very excited to be laying the groundwork for our move into the controlled substances world of psychedelics.” Being awarded the license would allow Pure Extracts to carry out extraction research and development into psychedelic compounds such as psilocybin and psilocin, preparing the Company for an eventual legislative move towards the legalization of psychedelics in the near future. In addition to its application for a Dealers License under Health Canada, Pure Extracts also recently announced that it had signed a letter of intent (“LOI”) with The Nutraceutical Medicine Company Inc. (“PURICA”), owner of the PURICA(TM) brand of full-spectrum mushroom derived wellness products, to both support Pure Extracts’ expansion into the functional mushroom sector while also seeking to jointly develop a series of CBD-full-spectrum mushroom wellness combinations (https://ibn.fm/OPJ8q). Pure Extracts, which is set to launch its own-branded functional mushrooms-derived product line under the ‘Pure Mushrooms’ brand name in early 2021, has long sought to develop its expertise within the functional mushrooms product segment, with the sector recently witnessing a surge in consumer demand given its stress-relieving and immune system-supportive properties. A product launch with PURICA(TM) would allow Pure Extracts to effectively marry the twin segments of full-spectrum mushroom extracts and CBD and would position Pure Extracts at the confluence of two powerful trends – namely, the rapid adoption of CBD oil as a mainstream medicinal product and the explosive growth of functional mushroom wellness products. Ben Nikolaevsky remarked in relation to the potential partnership, “We are excited to be working with the experts at PURICA(TM) on functional mushroom products and novel CBD formulations. They have an impressive history of product development, customer retention and an unwavering dedication to high standards.” For more information, visit the company’s website at www.PureExtractsCorp.com. NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at https://ibn.fm/PULL

• Loop Insights is an innovative data technology solutions provider developing contactless, digital wallet-based marketing, tracing and notification services
• During the COVID era, Loop’s venue management solution serves as a companion to contactless ticketing, and testing allowing attendees to receive alerts and notifications as well as proof of testing or vaccination and event / venue managers to monitor the same risk and deliver venue tracing alerts directly integrated with rapid testing.
• Following on the heels of the NBA’s massive COVID-free protective “bubble” experiment for the pro basketball season and playoffs, Loop served as the tech resource for two NCAA bubble events and successfully provided organizers the data they needed
• Loop is now partnering with rapid COVID test supplier Empower Clinics and aviation marketing consulting firm SimpliFlying to provide an international travel virus-protection bubble program, as well as a film industry bubble
• Loop intends to uplist from its TSX.V position to the broader TSX exchange, and then if successful to file with the Securities and Exchange Commission (“SEC”) in the United States to list on the NASDAQ

During the final weeks of 2020, the medical community has begun to experience real optimism in pushing back against the novel coronavirus pandemic that has sickened nearly 75 million people worldwide as of a week before Christmas, taking the lives of more than 1.6 million, and leaving some 20.5 million still in the throes of the illness with the Christmas holiday rapidly approaching (https://ibn.fm/MDktc).

With the rollout of one vaccine believed to be safe and effective in combating COVID-19 happening now, and additional vaccine approvals expected in the near future (https://ibn.fm/1Ivo8), business industry leaders are also tentatively beginning to adopt event and venue “bubble” practices that allow them to resume in-person, revenue-building activities while attempting to prevent infected people from attending. Bubble planning includes efficiently identifying any potential breach of the event / venue infection security net so that organizers can effectively provide contact-tracing warnings to participants who may have been exposed, as addressed in a report by event news outlet EventMB (https://ibn.fm/xRyvx).

Vancouver-headquartered Loop Insights (TSX.V: MTRX) (OTCQB: RACMF) is dedicating much of its focus on Internet of Things (“IoT”)-based contactless solutions to enabling renewed event / venue activity. The company has already successfully provided end-to-end venue tracing and alert notifications for two NCAA Division 1 basketball events and is expanding on its successes with bubble planning in non-sports markets such as the film and travel industries, as well as new sports events in 2021.

“There is simply no way to overstate the implications of our live environment Venue Bubble successes in Florida and Las Vegas over the past 10 days,” Loop Insights CEO Rob Anson stated about the NCAA events (https://ibn.fm/aLSVV). “With the whole world watching, including professional sports leagues and teams, college sports leagues and teams, world-renown venues and hospitality companies, Loop hit it out of the park and provided the world with the empirical data necessary to demonstrate our bubble solution is nothing short of world-class.”

The professional NBA basketball league set the initial standard for sports-related virus bubbles, creating a $190 million isolation zone at Florida’s Walt Disney World during the final eight games of the 2019–20 regular season and throughout the playoffs. The bubble was enacted in six phases between June and October, and no cases of COVID-19 were recorded by the teams participating in the bubble (https://ibn.fm/AUrR6).

Loop Insights’ IoT contactless venue management solution deployed in the NCAA events includes using smart wallet pass technology to manage tracing, testing, notifications and marketing. Attendees enter their personal information upon arrival, including their name and how to contact them, without having to rely on the exchange of hand written forms. The mobile wallets are used to authenticate the attendees’ information and to allow the exchange of information between the event / venue managers and the attendees regarding the data the venue requires, as explained in an October Loop webcast demonstrating the platform’s performance (https://ibn.fm/Q0feV).

The company’s recently announced expansion into virus-free bubble projects for the film industry (https://ibn.fm/dNvjQ) and the travel industry include a standout partnership with medical testing innovator Empower Clinics (CSE: CBDT) (OTC: EPWCF) (FRA: 8EC) and an MOU with aviation marketing consulting firm SimpliFlying to create an international airline travel bubble solution (https://ibn.fm/dFXHB).

Empower’s rapid antigen and antibody tests produce results in 15 minutes, providing the potential for a sense of security during the pandemic to airlines, cruise ships and the 182 countries currently in full or partial shutdown (https://ibn.fm/zpE9Q). The partners’ travel bubble product is now advancing talks for an agreement with the national tourism boards of the Dominican Republic, the Cayman Islands, the Bahamas, Jamaica and the Turks & Caicos islands, as well as the Iberostar, Bahia Principe and Hyatt Resorts, according to the company’s announcement.

Loop also recently announced its digital wallet and venue platform will support English, French and Spanish initially — a capability considered necessary as part of the partnership’s pursuit of nationwide agreements, particularly as Canada considers a unified solution with tracing, testing, and vaccination certification (https://ibn.fm/vAIfc).

The announcement includes notice that the company received $4.6 million from the exercise of warrants up to Dec. 10, which eliminates the need for any financing with the exception of strategic client partners that may want to invest in Loop in order to participate in its growth. Loop currently lists on the TSX.V and intends to uplist to the broader TSX exchange to increase its investment potential. If the TSX uplisting is successful, the company will eventually pursue filings with the Securities and Exchange Commission (“SEC”) in the United States to potentially list on the NASDAQ (https://ibn.fm/EZcxq).

For more information, visit the company’s website at www.LoopInsights.ai

NOTE TO INVESTORS: The latest news and updates relating to RACMF are available in the company’s newsroom at https://ibn.fm/RACMF

• “Forbes” article reports that EVs are “growing part of the automotive mainstream.”
• Big automakers rushing to bring EVs to market.
• evTS updated FireFly ESV incorporates best features from previous models, adds customizable upgrades.

More than a hundred years ago, the first electric vehicle (“EV”) was introduced, but the market has been slow to adopt the technology. Today, however, a “Forbes” article reports that if the “almost universal rush by manufacturers to bring fleets of wholly practical EVs to market is a meaningful indicator, we’re fast approaching the EV tipping point” (https://ibn.fm/FrecC). That’s exciting news for ev Transportation Services (“evTS”), the designer, developer and manufacturer of the FireFly ESV(R), a lightweight commercial utility EV with a range of 100-plus miles on a single charge — more than any other EV in its class. The commercial utility EV market is expected to see a dramatic increase in growth as companies continue to be pressured by both regulators and consumers to reduce their carbon footprint. According to BloombergNEF, the demand for this segment of the industry in the United States, China and Europe is expected to grow at a 33% CAGR from 2019 to 2028. Here is additional evidence of the upcoming boom for companies involved in the EV industry:

• Big three U.S. auto manufactures are directing profits from SUVs toward the development of clean, EV tech.
• General Motors plans to introduce 20 EVs over the next two years.
• Volkswagen will cease development of new internal-combustion-powered cars by 2026.
• California Gov. Gavin Newsom issued an executive order in September 2020 outlawing the sale of gas- and diesel-powered vehicles by 2035; New Jersey may be headed to the same decision.
• China requires that EVs account for 25% of domestic car sales within five years.
• By 2025 gas- and diesel-powered vehicles will be banned in Norway.
• By 2030 gas- and diesel-powered vehicles will be banned in Holland.
• By 2040 gas- and diesel-powered vehicles will be banned in Europe, the UK and France.
• Tesla, a pioneering EV company, has turned a profit in each of the last five quarters, despite the fact 2020 has seen a worldwide pandemic that has decreased car sales.

Leading the charge forward in this new world of electric vehicles is ev Transportation. The company’s FireFly ESV is specifically designed to meet the needs of parking enforcement, security, on demand urban delivery, and grounds maintenance. This lightweight vehicle can operate at speeds up to 50 mph, with a 100-plus mile range on a single charge. The modular bed design is customizable for specific purposes. Earlier this year, ev Transportation announced its newest FireFly, the 2021 model. This new version incorporates all of the best features from previous models and adds upgrades that include a bigger cab with more leg room; improved in-cabin experience with a more modern feel; and a new windshield design with improved visibility as well as real-time remote diagnostics and 360-degree video monitoring. The new model arrives just in time. According to the Allied Market Research report, the global electric vehicle market is projected to reach $802.81 billion by 2027 (https://ibn.fm/icTUN), and ev Transportation is strongly positioned in the burgeoning space. The company has already inked a deal with ADOMANI Inc., a leading provider of EVs, to provide 120 FireFly ESV vehicles (https://ibn.fm/EeKAY). This partnership will help expand sales in California and surrounding states. evTS is a specialty vehicle manufacturer that produces purpose built, light weight, electric commercial utility vehicles and fleet management solutions. Based in Boston, the company is currently focused on the essential-services transportation and urban mobility markets. For more information, visit the company’s website at www.evtaas.com. NOTE TO INVESTORS: The latest news and updates relating to ev Transportation Services are available in the company’s newsroom at https://ibn.fm/EVTS

• The company is scheduled to conduct three clinical trials in 2021 for Berubicin – two Phase II and the first-ever Phase I in pediatric patients
• FDA modified the trial design to designate overall survival as the trial’s primary endpoint
• The market for brain tumor therapies is expected to grow at a CAGR of 10% and reach an estimated $1.6 billion in 2025

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, announced that it obtained the Food and Drug Administration’s Investigational New Drug (“IND”) approval for its lead drug candidate Berubicin, according to a company press release on December 17, 2020 (https://ibn.fm/2Tin7). The press release was followed a day later by a public conference call during which the company’s CEO John Climaco and CMO Sandra Silberman, M.D., Ph.D. discussed the IND approval, as well as what that means for CNS Pharmaceuticals. The IND approval will allow the company to move forward with the plans for the Phase II trial of Berubicin in adults with Glioblastoma Multiforme (“GBM”) who have failed first-line therapy. GBM is an aggressive form of brain cancer that grows quickly. The current standard of care for those diagnosed with GBM is surgical resection followed by radiation therapy with temozolomide. There is not a significant increase in the survival rate for those who use this standard of care. In 2017, CNS entered a collaboration and asset purchase agreement with Reata Pharmaceuticals, Inc. (NASDAQ: RETA) and acquired all the Phase I trial information for Berubicin. Based on the limited information received, Berubicin appears to be the first anthracycline to cross the blood-brain barrier. The Phase I trial of Berubicin was completed by Reata over 14 years ago. One of the Phase I trial participants survived and is living cancer-free. Two others saw a significant reduction of the tumor’s size – up to 80 percent. CNS holds an exclusive worldwide license to the Berubicin chemical compound. A sub-licensee partner, WPD Pharmaceuticals, will be conducting two trials in Poland during 2021, including the first-ever Phase I pediatric trial of Berubicin. During the conference call, Silberman stated that this trial has expanded to cover additional types of brain tumors, not just GBM, in pediatric patients. The planned Phase II trial will evaluate the efficacy of Berubicin in patients with GBM who have failed the primary course of treatment for their tumor. The results will compare Berubicin to one standard of care, Lomustine, in a 2 to 1 randomization of patients who will receive one of these drugs. The trial has been designed to allow for the interim analysis of data to demonstrate the differences in the efficacy of the treatments. One modification made by the FDA for the previously disclosed trial design from CNS is designating the overall survival as the study’s primary endpoint, not just the efficacy. CNS believes that the trial has the potential to provide relevant data to the FDA, which may allow for an expedited pathway to approval for Berubicin. There is, however, no assurance that the FDA will interpret the data as such and approve the expedited pathway or further development. The IND approval and the upcoming clinical trials can help position CNS Pharmaceuticals as a market leader in the fast-growing sector of brain tumor therapies treatments. The overall global market for brain tumor therapeutics is expected to grow substantially from 2020 to 2025, at a CAGR of 10%. The 2019 market was valued at $1.1 billion and is expected to increase to $1.6 billion in 2025 (https://ibn.fm/BvYO2). According to John Climaco, CNS Pharmaceuticals will transform the next several months as Berubicin clinical trials begin. “We are entering an area with significant unmet medical need since the current treatment paradigm for GBM remains bleak, as this aggressive and currently incurable form of brain cancer continues to claim high mortality rates. We have a tremendous opportunity ahead of us as we continue our mission to improve patient outcomes for GBM and build on the promising results demonstrated by Berubicin in its Phase 1 clinical trial,” he added. For more information, visit the company’s website at www.CNSPharma.com NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP

• By September 2020, growth rate of electric vehicle market increased to over 11% YoY
• September 2020 marked record month for the EV industry, as 345,000 electric vehicles were sold globally – accounting for 4.9% of total automotive sales
• Increase in EV sales due to combination of policy shifts, technological innovations
• Net Element, through intended merger with privately held Mullen Technologies, expects to begin marketing Dragonfly K50 sports car in United States by Q2 2021

The winds of change are blowing as global warming and climate change-induced catastrophes are waking the world to the imminent need to shift towards green energy options. Net Element (NASDAQ: NETE), a financial technology company undergoing a complete transformation of its business model by entering into a definitive agreement to merge with privately-held Mullen Technologies, seems to have gained entry into the recently burgeoning electric vehicle industry at precisely the right time. Following from Net Element’s decision to enter into a binding Letter of Intent to merge with privately-held Mullen Technologies Inc. in mid-June 2020, NETE announced provisional plans to divest itself of its legacy payments-as-a-service transactional model and alter its operational focus towards the electric vehicle space. The timing could not have been any more propitious; in a dramatic turnaround to the dismal sentiment surrounding the sector in the early part of 2020, September 2020 proved to be a spectacular month for global passenger plug-in electric vehicle sales; sales volumes of electric vehicles touched 345,000 over the course of the month, equivalent to 4.9% of total global automobile sales (https://ibn.fm/CFqDW). More remarkably, after the first nine months of the year, global electric vehicle sales volumes amounted to 1.784 million units – a total equivalent to an 11 percent growth rate over the identical time frame in 2019, and equal to 3.4 percent of total vehicle sales over the nine-month period. Oddly, the increase in electric vehicle sales growth rates has come about amid a record decline in crude oil and gasoline prices – which in turn have led to a decline in the cost of ownership of traditional internal combustion engine-powered vehicles. Rather, the growth has been spurred by the confluence of two trends driving the industry’s growth—namely, policy initiatives and technological advancements. In early November 2020, the United Kingdom announced that the sale of new gasoline and diesel-fueled cars would be banned from 2030 onwards, bringing the original deadline forward an entire decade (https://ibn.fm/sn17o). The UK’s policy change followed in the wake of Sweden, which similarly moved towards introducing a ban on the sale of internal combustion-powered vehicles from 2030 onwards; the policy shift has already led to a dramatic transformation in the nation’s automotive market, with electric vehicles making up nearly 28% of Sweden’s new car sales over the first three quarters of the year. However, policy shifts have not been the sole driver behind the dramatic increase in EV sales in 2020. Electric vehicles have been the beneficiary of a series of technological innovations within the sector, byproducts of the vast increase in the capital expenditure and research within the product segment. Over the past year, a number of major automotive OEMs have committed to significant upfront investments in developing their EV portfolios, with Ford announcing that it would invest $11.5 billion on EV models by 2022 while the Volkswagen Group has forecast achieving 1 million EV sales by 2023. More importantly, a greater focus on EVs has led to a greater proliferation of choice available to consumers, with IHS Markit predicting that there will be 130 EV models available to US consumers by 2026, from 43 different automobile manufacturers (https://ibn.fm/OFVyb). Although the merger between Net Element and Mullen Technologies is not due for completion until 2021, Mullen has already set itself a number of lofty ambitions – chief of amongst which is the desire to reach a production threshold of 35,000 vehicles per annum by 2026. With Mullen’s initial two models already in the works and with the global EV sector set to skyrocket in terms of value over the course of the next decade, Net Element finds itself in the ideal position to capitalize from one of the biggest shifts in consumer behavior the world has ever seen. For more information, visit the company’s website at www.NetElement.com. NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE

• Market analysts foresee a revenue-building trend in the global autonomous robotic security during the coming decade, and autonomous robot developer Knightscope is in a competitive position to take advantage of the trend
• Many AI-enhanced robot sentries are already making appearances in the news, such as flying drones patrolling military bases and inventory-managing machines serving retail operations
• Knightscope’s security robot models include stationary products as well as mobile machines that patrol indoor and outdoor locations
• The models include features such as 360-degree eye-level HD streaming video, face and license plate recognition, and infrared thermal detection
• Knightscope has built a cadre of more than 17,000 investors through its Reg A+ offerings, among whom are many law enforcement and private security professionals who have their own insights on the security industry

Little by little, it appears the age of robotic sentinel patrols is becoming a reality. While not the apocalyptic vision of science fiction standards ranging from the X-Men to Robocop, today’s news outlets are increasingly carrying reports about AI-driven flying drones (https://ibn.fm/1YFYj), network-patrolling software platforms (https://ibn.fm/rVmPT), product transports (https://ibn.fm/NQmWL) and inventory-managing machines (https://ibn.fm/g2son).

Autonomous security innovator Knightscope has its own vision of robotics efficiency, developing models designed for differing vigilance needs — its K1 robot is a stationary machine, while the K3 can rove around, monitoring essential functions in indoor environments. The K5 is an outdoor-suitable machine that can manage environs designed to allow wheelchair access, including parking lots and walkways.

Knightscope’s impetus is creating a robotic force that can reduce company dependence on personnel who may be subject to inattention in the performance of repetitive, routine tasks and who may be subject to physical harm in dangerous circumstances.

“If you can imagine putting a human being into a place where they’re doing the same thing over and over and over again, they become ineffective very, very quickly,” Marketing and Sales Vice President Stacy Stephens said in a video report about the company’s products (https://ibn.fm/OeM5R). “You can also imagine having to put somebody in the line of fire in a dangerous situation — a robot doesn’t care about that. You put them in there instead of a human being, you make it safer and much more productive.”

The robots are already being deployed by entities such as hospitals, police departments, Fortune 1000 companies and most recently the federal government’s Veterans Administration (https://ibn.fm/1uJpn). They feature technology that helps them fulfill a variety of data collection tasks, such as recognition ability for people, faces, license plates, thermal fluctuations and signals.

Features such as 360-degree eye-level HD streaming video and speakers for live or recorded communication make them responsive to their environments and allow human monitors to interact with the environment as well.

“If you just look at the metrics, crime has a trillion dollar negative economic impact on the U.S. every single year. It’s a hidden tax we all pay in blood, tears and treasure,” CEO William Santana Li said during a recent fireside chat hosted by IPO Edge in partnership with Florida trade group The Palm Beach Hedge Fund Association (https://ibn.fm/fFg1b). “And the guards and the officers, frankly, just don’t have the tools that we should provide to them as a country. … If you would have told me back in 2013 when we started the company that the entire nation would be focused (now) on reimagining public safety, we’re in the middle of a pandemic and the robots are immune, like, this is a science fiction kind of script but, you know, here we are. Perfect timing.”

Knightscope is privately held, but its more than 17,000 investors include many of the people most affected by the robot models’ footprint — security officers of large corporations, shopping mall directors, municipal police officers and federal agents.

Analysts at Research Dive report the global autonomous security robots market is expected to experience significant growth between now and 2027 (https://ibn.fm/bKh87), and Knightscope’s ground-up product profile puts it in a competitive position as market forces unfold.

For more information, visit the company’s website at www.Knightscope.com. Visit www.Knightscope.com/invest for a summary of Knightscope as an investment, with a blue Instant Messaging button for direct contact with their CEO.

DISCLAIMER: You should read the Offering Circular and risks related to this offering before investing. This Reg A+ offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight

• SGTM brings environmentally friendly, sustainable approach to tree and storm waste disposal
• Company processes its tree debris into variety of organic mulch products, was recently awarded contracts to market its products through The Kroger Co., Circle K stores
• SGTM recently awarded IPEMA certification to commence recycling waste into playground surfacing material sector, which is expected to be valued at over $5.8 billion by 2026
• Active 2020 hurricane season has led to increased demand for SGTM’s storm, tree recovery services

Sustainable Green Team (OTC: SGTM) has historically sought to provide a synergistic and environmentally beneficial solution to tree and storm waste disposal, helping to alleviate the environmental burdens which have traditionally afflicted landfills and disposal sites around the country. Accordingly, throughout its 40-year corporate tenure, SGTM has prided itself in building a reputation as an environmentally responsible enterprise, focused on being “stewards of the environment” across all aspects of its business. Sustainable Green Team’s vertically integrated operations have been founded around the central tenet of sustainability—a trait which has been prevalent across all facets of its operations. Following the collection of tree debris through its tree services division and collection sites, the company subsequently transfers the amassed tree biomass through to the processing divisions for recycling and manufacturing into a variety of organic, attractive, next-generation mulch products, which are then packaged and sold to retailers, landscapers and for general agricultural purposes. SGTM has found a willing audience for its products, revealing recently that its subsidiary, Mulch Manufacturing Inc., had been awarded contracts to supply The Kroger Co. and Alimentation Couch-Tard’s Circle K subsidiary with premium grade organic mulch products over the coming year (https://ibn.fm/0AJnV). “We have been blessed to be offered these amazing opportunities from large chain accounts to help further expand our brand and overall exposure,” stated SGTM CEO and Director Tony Raynor (https://ibn.fm/OctuN). In addition to its efforts in recycling tree and storm waste into commercialized mulch products, the Sustainable Green Team has recently gained the International Play Equipment Manufacturers Association (“IPEMA”) certification to commence recycling waste into playground surfacing material. With a growing demand for playground surfacing material from schools, commercial athletic facilities and recreational spaces, SGTM’s new product line is expected to help the company tap into a market estimated to rise to a value of over $5.8 billion by the end of 2026, a 150% increase from 2017’s $3.7 billion (https://ibn.fm/vqDhT). The 2020 Atlantic hurricane season was destined for the record books before it even started. Meteorologists began calling for an above-average storm season as early as December 2019 (https://ibn.fm/WzeZ7), with predictions of 15-20 named storms and four major hurricanes. However, eclipsing initial forecasts, the Atlantic hurricane season has thus far been comprised of 30 tropical storms, 13 hurricanes and six major hurricanes with initial assessments estimating the cumulative economic impact of the storms at an estimated $38 billion (https://ibn.fm/3LjQT). The active storm season has led to a commensurate increase in the demand for tree recovery/collection services which has translated into greater sales for the company’s end products. “Getting paid for your feedstock in the mulch business is a recipe for success and great profit margins,” said Raynor. “Storm recovery is a multibillion-dollar business, and we are prepared to help in any cleanup process.” To learn more about Sustainable Green Team Ltd., view the investor presentation at https://ibn.fm/EBY3V. NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

• CNSC partners with InvestorBrandNetwork to maximize communication, refine messaging and outreach.
• CannAssist focused on marketing Xceptol consumer brand, which provides products featuring proprietary CiBiDinol technology.
• IBN brings 15-plus years of experience assisting more than 500 client partners improve communications within investment community.

Recognizing the critical nature of communications to the success of a business, CannAssist International (OTCQB: CNSC) has selected to partner with InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities (https://ibn.fm/o1Oav). CannAssist, a biotechnological pharmaceutical and wellness company, owns Xceptor Labs, an R&D and raw material manufacturer, which also has its own product line. “We are pleased to engage IBN to maximize our communication with existing and potential shareholders while refining our overall messaging and outreach,” said CannAssist CEO Mark Palumbo. Currently, CannAssist is focused on marketing its Xceptol consumer brand, which provides products that feature Xceptor Labs’ proprietary CiBiDinol technology. According to CannAssist, CiBiDinol is a method of creating CBD products that have better absorption than other oil-based products currently available. CiBiDinol provides CBD in a format that is more in line with the body’s natural bioactivity, the company said. Specifically, CiBiDinol is designed to tackle issues with oil-soluble CBD molecules, such as delivery, bioavailability and short shelf-life. CannAssist notes that the product in the brand also offers more predictable potency. The CannAssist story is certainly one worth telling, and IBN is focused on telling that story through a variety of ways. IBN has built an investor-based distribution network of 5,000-plus key syndication outlets; the company also produces various newsletters and manages a variety of social media platforms, wire service, blogs and other outreach tools. The purpose of the IBN partnership is to generate greater awareness for CannAssist International Corp. “The cannabidiol market has been on fire since the 2018 Farm Bill was signed into law,” said IBN director of client solutions Chris Johnson. “In 2018, the global CBD market was valued at $4.6 billion, and it’s forecast to reach $23.6 billion by 2025, according to Grand View Research. CannAssist is uniquely positioned to capitalize on this market growth. “Based on current revenue from raw material sales, retail sales and the Xceptol brand’s international distribution, CannAssist expects to reach first-year sales of $5 million,” Johnson continued. “We’re excited to customize our comprehensive suite of corporate communications solutions for the company as it seeks to expand its product pipeline and achieve steady sales growth in the years ahead.” Johnson noted that with 15-plus years of experience assisting more than 500 client partners improve communications within the investment community, IBN is the ideal organization to work alongside CannAssist. Through its family of 50-plus trusted brands and millions of social media followers, IBN is uniquely positioned to offer CannAssist the essential expertise, insight and tools to reach a wider audience of investors, consumers and more. CannAssist, owner of Xceptor Labs, is a biotechnological pharmaceutical and wellness company. Established in May 2017, CannAssist is headquartered in San Diego County, California, and markets its consumer line of cannabidiol (“CBD”) products under the Xceptol brand. For more information, visit the company’s website at www.CannAssistInternational.com. NOTE TO INVESTORS: The latest news and updates relating to CNSC are available in the company’s newsroom at https://ibn.fm/CNSC

• POAI sent letter to shareholders requesting attendance at virtual Special Meeting on December 30, 2020
• Meeting will address reincorporation of POAI in Nevada
• Reincorporation expected to save POAI approximately $158,000 annually in state taxes
• Shareholders can vote online or by telephone, detailed instructions outlined in proxy materials

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, recently sent a letter to all shareholders urging them to attend a virtual Special Meeting of Stockholders (the “Meeting”). Originally scheduled for December 1, 2020, the Meeting will be reconvened on December 30, 2020 at 3:00 p.m. CST, where all shareholders will be requested by the Board of Directors and management of POAI to vote “FOR” the proposals put forward at the Meeting. The Board of Directors and management of POAI are proposing that the corporation reincorporates in Nevada for the purpose of eliminating its obligation to pay the Delaware franchise tax of approximately $170,000 per year. By reincorporating in Nevada, POAI management believes that the company can save approximately $158,000 annually in state taxes. “We are asking you to vote for allowing the company to reincorporate in the state of Nevada, moving away from Delaware,” writes POAI CEO Carl Schwartz (https://ibn.fm/UsMtz).  “First and foremost, the reincorporation in Nevada will eliminate our obligation to pay the injurious annual Delaware franchise tax, which is currently equal to approximately $170,000 per year. We can save approximately $158,000 annually in state taxes by reincorporating in Nevada. Also, we believe that for the reasons described in the proxy materials, in general, Nevada law provides greater protection to our directors, officers and the company than Delaware law.” In order for the reincorporation to be approved, the proposal must receive a “For” vote from the majority of outstanding shares of common stock of the company. At POAI’s recent Annual Meeting, the reincorporation vote received a larger amount of “For” votes than “Against” votes; however, the amount required for the vote to pass fell short for a majority of the outstanding shares. Management at POAI is urging all shareholders to vote their shares online or by telephone by following the instructions outlined in their proxy materials. POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (“PDx”) smart tumor profiling platform to provide oncologists with a roadmap to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow. For more information, visit the company’s website at www.Predictive-Oncology.com. NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI